Ocugen, Inc. (OCGN)
1.33
+0.01
(+0.76%)
USD |
NASDAQ |
Aug 31, 16:00
1.37
+0.04
(+3.01%)
After-Hours: 04:52
Ocugen Total Long Term Debt (Quarterly) : 4.788M for June 30, 2026
Total Long Term Debt (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Long Term Debt (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 4.788M |
| March 31, 2026 | 32.45M |
| December 31, 2025 | 32.29M |
| September 30, 2025 | 32.11M |
| June 30, 2025 | 31.97M |
| March 31, 2025 | 31.09M |
| December 31, 2024 | 31.98M |
| September 30, 2024 | 6.306M |
| June 30, 2024 | 6.404M |
| March 31, 2024 | 6.243M |
| December 31, 2023 | 6.367M |
| September 30, 2023 | 5.935M |
| June 30, 2023 | 6.046M |
| March 31, 2023 | 5.763M |
| December 31, 2022 | 5.876M |
| September 30, 2022 | 6.029M |
| June 30, 2022 | 5.642M |
| March 31, 2022 | 2.911M |
| December 31, 2021 | 2.943M |
| September 30, 2021 | 2.973M |
| June 30, 2021 | 3.002M |
| March 31, 2021 | 3.077M |
| December 31, 2020 | 2.212M |
| September 30, 2020 | 3.198M |
| June 30, 2020 | 6.163M |
| Date | Value |
|---|---|
| March 31, 2020 | 1.698M |
| December 31, 2019 | 1.235M |
| September 30, 2019 | 1.319M |
| June 30, 2019 | 0.00 |
| March 31, 2019 | 6.918M |
| December 31, 2018 | 1.017M |
| September 30, 2018 | 0.00 |
| June 30, 2018 | 0.00 |
| March 31, 2018 | 0.045M |
| December 31, 2017 | 0.178M |
| September 30, 2017 | 0.324M |
| June 30, 2017 | 0.47M |
| March 31, 2017 | 0.615M |
| December 31, 2016 | 0.761M |
| September 30, 2016 | 0.907M |
| June 30, 2016 | 1.053M |
| March 31, 2016 | 1.198M |
| December 31, 2015 | 1.344M |
| September 30, 2015 | 1.49M |
| June 30, 2015 | 1.636M |
| March 31, 2015 | 1.737M |
| December 31, 2014 | 1.75M |
| September 30, 2014 | 0.464M |
| June 30, 2014 | 0.00 |
| March 31, 2014 | 0.00 |
Total Long Term Debt Definition
Represents a company's total debt maturing for more than 12 months of the reporting period.
Total Long Term Debt (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Long Term Debt (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 59.55M |
| Biogen, Inc. | 8.355B |
| Gilead Sciences, Inc. | 26.25B |
| MannKind Corp. | 434.28M |
| Vertex Pharmaceuticals, Inc. | 1.978B |